Rodr´ıguez-Escrich et al.
CDCl3) δ 141.0, 136.7,135.1, 133.7, 129.3, 128.4, 128.3, 127.9,
127.6, 127.4, 127.3, 126.8, 126.2, 125.3, 68.3, 65.8, 19.2. IR (KBr)
3060, 2956, 1491, 1460, 1447, 901, 764, 748, 721,702, 648, 623,
586 cm-1. MS (CI, NH3) m/z 286 (C21H18O, 0), 304 (100). Anal.
Calcd for C21H18O: C, 88.07; H, 6.35. Found: C, 88.16; H, 6.34.
Epoxide Ring-Opening Reactions.30 General Procedure 2
(GP2). A mixture of the oxirane (1.0 mmol), LiClO4 (214 mg, 2.0
mmol), and amine (10.0 mmol) was heated at 100 °C under N2.
After the complete disappearance of the oxirane, the excess of amine
was distilled under reduced pressure. The residue was dissolved in
CH2Cl2 (10 mL), washed with water (2 × 100 mL), dried (Na2SO4),
and concentrated under reduced pressure to give the crude product,
which was purified by chromatography on silica gel pretreated with
Et3N (2.5% v/v) using hexanes/EtOAc as eluent. General Proce-
dure 3 (GP3). A solution of the oxirane (1.0 mmol) in anhydrous
acetonitrile (2 mL) was treated with LiClO4 (1.07 g, 10.0 mmol)
and the cyclic amine (10.0 mmol), and the reaction mixture was
stirred at 80 °C under nitrogen atmosphere until the complete
disappearance of the starting oxirane (ca. 24-96 h). The reaction
mixture was diluted with water (25 mL) and extracted with
dichloromethane (3 × 25 mL). The organic layer was washed with
water, dried over anhydrous Na2SO4, and concentrated in vacuo to
give a crude product. Purification by column chromatography on
silicagel pretreated with Et3N (2.5% v/v) and hexane/EtOAc as
eluent afforded analytically pure compounds.
(CI, NH3) m/z 385 (C27H31NO.H+, 100). Anal. Calcd for C27H31NO:
C, 84.11; H, 8.10; N, 3.63. Found: C, 84.32; H, 8.16; N, 3.64.
(R)-1,1,2-Triphenyl-2-pyrrolidine-yl-ethanol (1e). Following
the general procedure GP3 for oxirane 1 (1.0 mmol, 272 mg), and
pyrrolidine (0.82 mL, 10.0 mmol) for 48 h, compound 1e was
isolated (312 mg, 91%) as a white solid; mp 155 °C. [R]23D: +7.3
1
(c 0.96, CHCl3). H NMR (200 MHz, CDCl3): δ 7.86-7.83 (2H,
m), 7.33-6.77 (13H, m), 4.52 (1H, s), 2.28-2.16 (4H, m),
1.57-1.51 (4H, m). 13C NMR (50.3 MHz, CDCl3): δ 149.8, 146.1,
139.9, 130.1, 128.0, 127.3, 127.1, 126.8, 126.2, 125.9, 125.3, 125.2,
78.2, 76.4, 54.3, 23.3. IR (KBr): 3388, 3025, 2967, 2811, 1491,
1449, 1034, 746, 698, 636 cm-1. MS (CI, NH3) m/z 343
(C24H25NO.H+, 100). Anal. Calcd for C24H25NO: C, 83.93; H, 7.34;
N, 4.08. Found: C, 84.11; H, 7.36; N, 3.93.
(R)-2-(3-Clorophenyl)-1,1-diphenyl-2-piperidine-1-yl-etha-
nol (2a). Following the general procedure GP3 for oxirane 2 (1.0
mmol, 307 mg), and piperidine (1.0 mL, 10.0 mmol) for 48 h,
compound 2a was isolated (284 mg, 72%) as a white solid; mp
167 °C. [R]23D: -106.0 (c 1.12, CHCl3). 1H NMR (200 MHz,
CDCl3): δ 7.67-7.63 (2H, m), 7.36-6.92 (12H, m), 5.59 (1H, br
s), 4.49 (1H, s), 2.46-2.34 (2H, m), 2.06-1.96 (2H, m), 1.45-1.26
(6H, m). 13C NMR (50.3 MHz, CDCl3): δ 148.9, 145.4, 139.7,
133.3, 131.1, 129.4, 128.7, 128.0, 127.4, 127.0, 126.6, 126.4, 125.9,
125.6, 78.9, 77.0, 54.6, 26.8, 24.1. IR (KBr): 3290, 3060, 2934,
2851, 1597, 1493, 1476, 1449, 1084, 1055, 1034, 793, 146, 696,
665 cm-1. MS (CI, NH3) m/z 392 (C25H26ClNO.H+, 100). Anal.
Calcd for C25H26ClNO: C, 76.61; H, 6.69; N, 3.57; Cl, 9.05. Found:
C, 76.89; H, 6.70; N, 3.61; Cl, 9.30.
(R)-2-Piperidino-1,1,2-triphenylethanol (1a).7a Following the
general procedure GP2 for oxirane 1 (1.0 mmol, 272 mg), and
piperidine (1.0 mL, 10.0 mmol) for 24 h, compound 1a was isolated
(351 mg, 98%) as white crystals. All spectroscopic data matched
those reported in the literature.
(2R)-2-Azepan-1-yl-2-(3-chlorophenyl)-1,1-diphenyl-ethanol
(2b). Following the general procedure GP3 for oxirane 2 (1.0 mmol,
307 mg), and hexamethyleneimine (1.13 mL, 10.0 mmol) for 48 h,
compound 2b was isolated (290 mg, 72%) as a white solid; mp
161 °C. [R]23D: -55.3 (c 1.13, CHCl3). 1H NMR (200 MHz,
CDCl3): δ 7.66-7.63 (2H, m), 7.33-6.97 (12H, series of m), 5.08
(1H, br s), 4.76 (1H, s), 2.75-2.67 (2H, m), 2.42-2.36 (2H, m),
1.48-1.33 (8H, m). 13C NMR (50.3 MHz, CDCl3): δ 148.5, 145.3,
140.3, 133.3, 130.8, 129.1, 128.6, 127.9, 127.4, 126.9, 126.4, 126.3,
125.9, 125.8, 79.5, 77.2, 55.4, 29.2, 26.5). IR (KBr): 3573-3274
(2R)-2-Azepan-1-yl-1,1,2-triphenylethanol (1b). Following the
general procedure GP3 for oxirane 1 (1.0 mmol, 272 mg), and
hexamethyleneimine (1.13 mL, 10.0 mmol) for 24 h, compound
1b was isolated (334 mg, 90%) as a white solid; mp 160 °C. [R]23
:
D
1
-8.1 (c 1.99, CHCl3). H NMR (200 MHz, CDCl3): δ 7.75-7.57
(2H, m), 7.39-6.90 (13H, m), 5.51 (1H, br s), 4.78 (1H, s),
2.76-2.59 (2H, m), 2.48-2.31 (2H, m), 1.45-1.26 (8H, m). 13C
NMR (50 MHz, CDCl3): δ 149.1, 145.8, 138.2, 131.0, 127.8, 127.5,
127.2, 127.0, 126.8, 126.7, 126.2, 125.9, 125.7, 79.3, 78.0, 55.4,
29.2, 26.2. IR (KBr): 3402, 3084, 3059, 3023, 2918, 2843, 1493,
1449, 1317, 1148, 1055, 760, 748, 700 cm-1. MS (CI, NH3) m/z
371 (C26H29NO.H+, 100). Anal. Calcd for C26H29NO: C, 84.06; H,
7.87; N, 3.77. Found: C, 84.05; H, 7.96; N, 3.71.
(br), 3060, 3027, 2927, 2853, 1659, 1449, 1279, 762, 702, 638 cm-1
.
MS (CI, NH3) m/z 406 (C26H28ClNO.H+, 100). Anal. Calcd for
C26H28ClNO: C, 76.93; H, 6.95; N, 3.45; Cl, 8.73. Found: C, 76.98;
H, 6.91; N, 3.34 Cl, 8.51.
(R)-2-(2-Chlorophenyl)-1,1-diphenyl-2-piperidine-1-yl-etha-
nol (3a). Following the general procedure GP3 for oxirane 3 (1.0
mmol, 307 mg), and piperidine (1.0 mL, 10.0 mmol) for 72 h,
compound 3a was isolated (36 mg, 9%) as a white solid; mp 169
°C. [R]23D: -216.2 (c 1.39, CHCl3). 1H NMR (200 MHz, CDCl3):
δ 7.74-7.70 (2H, m), 7.60-6.55 (1H, series of m), 7.34-6.33
(11H, m), 5.81 (1H, br s), 5.33 (1H, s), 2.50-2.42 (2H, m),
2.06-2.0 (2H, m), 1.42-1.26 (6H, m). 13C NMR (50.3 MHz,
CDCl3): δ 149.3, 145.8, 136.1, 135.4, 133.2, 128.8, 128.1, 127.4,
126.2, 125.8, 125.6, 125.4, 78.9, 71.5, 54.0, 27.0, 24.2. IR (KBr):
3395, 3060, 3025, 2923, 2844, 2833, 2819, 1449, 1173, 1057, 1034,
748, 708, 665 cm-1. MS (CI, NH3) m/z 392 (C25H26ClNO.H+, 100).
(R)-2-(4-Fluorophenyl)-1,1-diphenyl-2-piperidine-1-yl-etha-
nol (5a). Following the general procedure GP3 for oxirane 5 (1.0
mmol, 290 mg), and piperidine (1.0 mL, 10.0 mmol) for 24 h,
compound 5a was isolated (350 mg, 93%) as a white solid; mp
151 °C. [R]23D: -123.0 (c 0.67, CHCl3). 1H NMR (300 MHz,
CDCl3): δ 7.67-7.64 (2H, m), 7.32-6.94 (10H, m), 6.83-6.78
(2H, m), 5.69 (1H, br s), 4.53 (1H, s), 2.39-2.35 (2H, m),
2.00-1.97 (2H, m), 1.42-1.37 (4H, m), 1.29-1.27 (2H, m). 13C
NMR (75 MHz, CDCl3): δ 163.2, 159.9, 149.0, 145.5, 132.6, 132.5,
127.9, 127.3, 126.7, 126.2, 125.7, 125.5, 114.4, 114.1, 78.7, 76.7,
54.5, 26.7, 24.1. IR (KBr): 3455, 3030, 3000, 2944, 2841, 1607,
1508, 1449, 1227, 1165, 1055, 748, 696, 550 cm-1. MS (CI, NH3)
m/z 371 (C25H26FNO.H+, 100). Anal. Calcd for C25H26FNO: C,
79.97; H, 6.98; N, 3.73. Found: C, 79.83; H, 6.94; N, 3.74.
(R)-2-Azocan-1-yl-1,1,2-triphenylethanol (1c). Following the
general procedure GP3 for oxirane 1 (1.0 mmol, 272 mg), and
heptamethyleneimine (1.26 mL, 10.0 mmol) for 48 h, compound
1c was isolated (72 mg, 18%) as a white solid; mp 149 °C. [R]23
:
D
-78.1 (c 1.21, CHCl3). 1H NMR (200 MHz, CDCl3): δ 7.73-7.69
(2H, m), 7.35-6.90 (13H, series of m), 5.38 (1H, br s), 4.80 (1H,
s), 2.74-2.59 (2H, m), 2.43-2.30 (2H, m), 1.50-1.21 (10H, m).
13C NMR (50.3 MHz, CDCl3): δ 149.1, 146.1, 138.1, 131.2, 127.9,
127.4, 127.2, 126.8, 126.5, 126.2, 125.8, 125.6, 79.6, 78.9, 54.8,
28.0, 27.3, 25.2. IR (KBr): 3416, 3075, 3046, 3021, 2927, 2855,
1493, 1449, 1319, 1175, 1121, 993, 972, 762, 746, 702 cm-1. MS
(CI, NH3) m/z 385 (C27H31NO.H+, 100). Anal. Calcd for C27H31NO:
C, 84.11; H, 8.11; N, 3.63. Found: C, 84.16; H, 8.11; N, 3.63.
(R)-2-(3,3-Dimethylpiperidine-yl)-1,1,2-triphenylethanol (1d). Fol-
lowing the general procedure GP3 for oxirane 1 (1.0 mmol, 272
mg), and 3,3-dimethylpiperidine (1.41 mL, 10.0 mmol) for 48 h,
compound 1d was isolated (380 mg, 99%) as a white solid; mp
147 °C. [R]23D: -131.5 (c 1.11, CHCl3). 1H NMR (200 MHz,
CDCl3): δ 7.69-7.65 (2H, m), 7.33-6.90 (13H, m), 5.56 (1H, s),
4.55 (1H, s), 2.47-2.36 (1H, m), 2.13 (1H, d, J ) 11.1 Hz),
1.93-1.78 (2H, m), 1.43-1.34 (2H, m), 1.07-0.98 (2H, m), 0.83
(3H, s), 0.69 (3H, s). 13C NMR (50 MHz, CDCl3): δ 149.2, 145.7,
137.1, 131.3, 127.9, 127.3, 127.2, 126.8, 126.6, 126.1, 125.6, 79.4,
77.1, 65.9, 54.2, 37.0, 31.5, 27.2, 26.8, 23.0. IR (KBr): 3417, 3064,
3025, 2938, 2817, 1495, 1449, 976, 750, 700, 654, 636 cm-1. MS
5350 J. Org. Chem. Vol. 73, No. 14, 2008